Europe close to meeting UNAIDS 90-90-90 target but considerable variability between countries
Dolutegravir-based ART effective and safe for HIV-positive people taking standard TB treatment
Breastfeeding with undetectable viral load: genuine uncertainty on risk should be communicated to women with HIV, say Swiss doctors
New role for Keith Alcorn at NAM
Neuropsychiatric side-effects lead only 1 in 40 to drop dolutegravir, French study shows
Giving gay men self-test kits increases testing by 50% – but STI tests decrease
UK research shows that black patients of West African and Caribbean origin have higher rates of chronic kidney disease
Starting treatment on the day of HIV diagnosis is acceptable and feasible for Thai patients
